MedPath
HSA Approval

EPHEDRINE NASAL DROPS BPC

SIN04850P

EPHEDRINE NASAL DROPS BPC

EPHEDRINE NASAL DROPS BPC

June 28, 1990

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SOLUTION

NASAL

Medical Information

R01AA03

ephedrine

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Active Ingredients

EPHEDRINE HCl

0.5% w/v

Ephedrine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EPHEDRINE NASAL DROPS BPC - HSA Approval | MedPath